
New long-term data from the phase 2b CLOVER WaM trial showed promising results for iopofosine I-131 (CLR 131) in relapsed/refractory Waldenstrom macroglobulinemia.
Read more: ow.ly/JqUx50Z2ie4
@CellectarBio
#WaldenstromMacroglobulinemia #IopofosineI131

English















